Importer of Controlled Substances; Notice of Registration; Hospira, 31986 [2014-12795]

Download as PDF 31986 Federal Register / Vol. 79, No. 106 / Tuesday, June 3, 2014 / Notices Suite D, Windsor, Colorado 80550, applied to be registered as a bulk manufacturer of Carfentanil (9743), a basis class of narcotic controlled substance listed in schedule II. The company plans to manufacture the above listed controlled substance for sale to veterinary pharmacies, zoos, and other animal and wildlife applications. Dated: May 28, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator. [FR Doc. 2014–12792 Filed 6–2–14; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE [Docket No. DEA–392] Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before July 3, 2014. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before July 3, 2014. Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, and dispensers of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (‘‘Deputy Assistant Administrator’’) pursuant to sec. 7(g) of 28 CFR pt. 0, subpt. R, App. In accordance with 21 CFR 1301.34(a), this is notice that on March 5, 2014, Alltech Associates, Inc., 2051 Waukegan Road, Deerfield, Illinois sroberts on DSK4SPTVN1PROD with NOTICES Jkt 232001 I I II II II II II II with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed. Dated: May 28, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2014–12795 Filed 6–2–14; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: MALLINCKRODT, LLC ACTION: Notice of application. BILLING CODE 4410–09–P DATES: 17:35 Jun 02, 2014 I [FR Doc. 2014–12793 Filed 6–2–14; 8:45 am] Notice of application. VerDate Mar<15>2010 Gamma Hydroxybutyric Acid (2010). Lysergic acid diethylamide (7315) Heroin (9200) ............................... Cocaine (9041) ............................. Codeine (9050) ............................. Hydrocodone (9193) ..................... Meperidine (9230) ........................ Methadone (9250) ........................ Morphine (9300) ........................... Schedule Dated: May 28, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator. Importer of Controlled Substances Application: Alltech Associates, Inc. SUPPLEMENTARY INFORMATION: Controlled substance The company plans to import these controlled substances for the manufacture of reference standards. Drug Enforcement Administration ACTION: 60015, applied to be registered as an importer of the following basic classes of narcotic or non-narcotic controlled substances: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before August 4, 2014. DATES: DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration; Hospira By Notice dated December 16, 2013, and published in the Federal Register on January 2, 2014, 79 FR 151, Hospira, 1776 North Centennial Drive, McPherson, Kansas 67460–1247, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Remifentanil (9739), a basic class of controlled substance listed in schedule II. The company plans to import Remifentanil for use in dosage form manufacturing. No comments or objections have been received. The DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Hospira to import the basic class of controlled substance is consistent with the public interest and in accordance with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA has investigated Hospira to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, and dispensers of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (‘‘Deputy Assistant Administrator’’) pursuant to sec. 7(g) of 28 CFR pt. 0, subpt. R, App. In accordance with 21 CFR 1301.33(a), this is notice that on January 16, 2014, Mallinckrodt, LLC., 3600 North Second Street, St. Louis, Missouri 63147, applied to be registered as a bulk manufacturer of the following basic classes of narcotic or nonnarcotic controlled substances: SUPPLEMENTARY INFORMATION: E:\FR\FM\03JNN1.SGM 03JNN1

Agencies

[Federal Register Volume 79, Number 106 (Tuesday, June 3, 2014)]
[Notices]
[Page 31986]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-12795]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration; 
Hospira

    By Notice dated December 16, 2013, and published in the Federal 
Register on January 2, 2014, 79 FR 151, Hospira, 1776 North Centennial 
Drive, McPherson, Kansas 67460-1247, made application by renewal to the 
Drug Enforcement Administration (DEA) to be registered as an importer 
of Remifentanil (9739), a basic class of controlled substance listed in 
schedule II.
    The company plans to import Remifentanil for use in dosage form 
manufacturing.
    No comments or objections have been received. The DEA has 
considered the factors in 21 U.S.C. 823(a) and 952(a) and determined 
that the registration of Hospira to import the basic class of 
controlled substance is consistent with the public interest and in 
accordance with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971. The DEA has 
investigated Hospira to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above named company is granted 
registration as an importer of the basic class of controlled substance 
listed.

    Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2014-12795 Filed 6-2-14; 8:45 am]
BILLING CODE 4410-09-P